Literature DB >> 20066449

Comorbidity of fibromyalgia and cervical myofascial pain syndrome.

Burcu Duyur Cakit1, Suhan Taskin, Baris Nacir, Irem Unlu, Hakan Genc, Hatice Rana Erdem.   

Abstract

The aims of this study are to determine the frequency of fibromyalgia syndrome (FMS) in patients with chronic cervical myofascial pain (CMP) and to investigate the FMS characteristics in CMP patients. Ninty-three patients with CMP and 30 age-matched healthy women were included in this study. Main outcome measures included visual analog scale (VAS), Beck Depression Inventory (BDI), and pain pressure thresholds. CMP patients were evaluated for the existence of FMS. The severity of FMS was assessed with total myalgic score (TMS) and control point score (CPS). Most common clinical characteristics of FMS were noted. Of the 93 CMP subjects, 22 (23.6%) patients fulfilled the classification criteria for FMS. Number of tender points were higher (p=0.0), while TMS (p=0.0) and CPS (p=0.0) values were lower in comorbid CMP and FMS patients than regional CMP group. There were statistically significant differences between regional CMP patients and comorbid CMP and FMS patients regarding presence of fatigue (p=0.0) and irritable bowel syndrome (p=0.022). There was no statistically significant difference between patient groups regarding VAS values (p>0.05). BDI values of the regional CMP were significantly lower than comorbid CMP and FMS patients (p=0.011). In conclusion, we found that nearly a quarter of CMP patients were comorbid with FMS, and psychological and comorbid symptoms were more prominent in comorbid patients. We thought that, these two syndromes might be overlapping conditions and as a peripheral pain generator or inducer of central sensitisation, MPS might lead to FMS or precipitate and worsen the FMS symptoms.

Entities:  

Mesh:

Year:  2010        PMID: 20066449     DOI: 10.1007/s10067-009-1342-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  27 in total

Review 1.  Fibromyalgia syndrome: a new paradigm for differential diagnosis and treatment.

Authors:  D M Brady; M J Schneider
Journal:  J Manipulative Physiol Ther       Date:  2001-10       Impact factor: 1.437

2.  Difference in pain relief after trigger point injections in myofascial pain patients with and without fibromyalgia.

Authors:  C Z Hong; T C Hsueh
Journal:  Arch Phys Med Rehabil       Date:  1996-11       Impact factor: 3.966

Review 3.  Myofascial pain syndrome and fibromyalgia.

Authors:  L B Goldman; N L Rosenberg
Journal:  Semin Neurol       Date:  1991-09       Impact factor: 3.420

4.  Managing myofascial pain syndrome: sorting through the diagnosis and honing treatment.

Authors:  James M Daniels; Tim Ishmael; Robert M Wesley
Journal:  Phys Sportsmed       Date:  2003-10       Impact factor: 2.241

Review 5.  A review of myofascial pain and fibromyalgia--factors that promote their persistence.

Authors:  Robert D Gerwin
Journal:  Acupunct Med       Date:  2005-09       Impact factor: 2.267

Review 6.  Muscle pain syndromes.

Authors:  Harden R Norman
Journal:  Am J Phys Med Rehabil       Date:  2007-01       Impact factor: 2.159

7.  Internal consistencies of the original and revised Beck Depression Inventory.

Authors:  A T Beck; R A Steer
Journal:  J Clin Psychol       Date:  1984-11

Review 8.  Fibromyalgia syndrome and myofascial pain syndrome. Do they exist?

Authors:  T W Bohr
Journal:  Neurol Clin       Date:  1995-05       Impact factor: 3.806

9.  Myofascial pain, fibromyalgia or fibrositis?

Authors:  J M S Pearce
Journal:  Eur Neurol       Date:  2004-07-13       Impact factor: 1.710

10.  Diagnosis and treatment of myofascial pain.

Authors:  H Kraus; A A Fischer
Journal:  Mt Sinai J Med       Date:  1991-05
View more
  13 in total

Review 1.  Clinical implication of latent myofascial trigger point.

Authors:  Derya Celik; Ebru Kaya Mutlu
Journal:  Curr Pain Headache Rep       Date:  2013-08

Review 2.  Management of fibromyalgia syndrome in 2016.

Authors:  Akiko Okifuji; Jeff Gao; Christina Bokat; Bradford D Hare
Journal:  Pain Manag       Date:  2016-06-16

3.  Change in Health-Related Quality-of-Life at Group and Individual Levels Over Time in Patients Treated for Chronic Myofascial Neck Pain.

Authors:  Marc Brodsky; Karen Spritzer; Ron D Hays; Ka-Kit Hui
Journal:  J Evid Based Complementary Altern Med       Date:  2016-08-18

Review 4.  Central sensitization: implications for the diagnosis and treatment of pain.

Authors:  Clifford J Woolf
Journal:  Pain       Date:  2010-10-18       Impact factor: 6.961

Review 5.  Effects of treatment of myofascial trigger points on the pain of fibromyalgia.

Authors:  Maria Adele Giamberardino; Giannapia Affaitati; Alessandra Fabrizio; Raffaele Costantini
Journal:  Curr Pain Headache Rep       Date:  2011-10

6.  The relationship between latent trigger points and depression levels in healthy subjects.

Authors:  Derya Celik; Ebru Kaya Mutlu
Journal:  Clin Rheumatol       Date:  2012-02-11       Impact factor: 2.980

Review 7.  Co-occurrence of pain syndromes.

Authors:  Giannapia Affaitati; Raffaele Costantini; Claudio Tana; Francesco Cipollone; Maria Adele Giamberardino
Journal:  J Neural Transm (Vienna)       Date:  2019-11-29       Impact factor: 3.575

8.  Benefits of massage-myofascial release therapy on pain, anxiety, quality of sleep, depression, and quality of life in patients with fibromyalgia.

Authors:  Adelaida María Castro-Sánchez; Guillermo A Matarán-Peñarrocha; José Granero-Molina; Gabriel Aguilera-Manrique; José Manuel Quesada-Rubio; Carmen Moreno-Lorenzo
Journal:  Evid Based Complement Alternat Med       Date:  2010-12-28       Impact factor: 2.629

9.  Fibromyalgia Syndrome and Vitiligo: A Novel Association.

Authors:  Oula S Khudhair; Faiq I Gorial; Ammar F Hameed
Journal:  Arch Rheumatol       Date:  2017-10-16       Impact factor: 1.472

10.  The Association of Skinfold Anthropometric Measures, Body Composition and Disease Severity in Obese and Non-obese Fibromyalgia Patients: A Cross-sectional Study.

Authors:  Mehmet Onat Çakit; Burcu Duyur Çakit; Hakan Genç; Seçil Pervane Vural; Hatice Rana Erdem; Meryem Saraçoğlu; Aynur Karagöz
Journal:  Arch Rheumatol       Date:  2017-06-05       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.